Healthcare - Biotechnology - NASDAQ - US
$ 0.91
-9 %
$ 71.2 M
Market Cap
6.07
P/E
Price Target
Average
380.22%
Revenue Forecast
Estimate
--1.41%
EBIT
Estimate
--84.10%
Net Income
Estimate
--162.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
CytomX Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CTMX of $4.37 , with forecasts ranging from a low of $2.5 to a high of $8 .
CTMX Lowest Price Target
Wall Street Target
2.5 USD
174.73%
CTMX Average Price Target
Wall Street Target
4.37 USD
380.22%
CTMX Highest Price Target
Wall Street Target
8 USD
779.12%
REVENUE FORECAST
Revenue Forecast Chart CTMX
EBIT FORECAST
EBIT Forecast Chart CTMX
NET INCOME FORECAST
Net Income Chart CTMX